Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer
Jinyou Liu(Central South University), Gangadhara R. Sareddy(The University of Texas Health Science Center at San Antonio)
Cited by 43
Related Papers
Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma
|Scientific Reports|2016|71
KDM1A inhibition augments the efficacy of rapamycin for the treatment of endometrial cancer
|Cancer Letters|2021|19